Allfine MedTech Completes Product Type Testing for World's First Miniaturized High-Precision Surgical Robot Platform

As an advanced technology capable of assisting doctors in medical diagnosis and auxiliary treatment, surgical robots have occupied an important position in the medical field since their inception due to their irreplaceability, strong auxiliary capabilities, and expandability, becoming a high-barrier focal point.

Nowadays, against the backdrop of insufficient medical resources, this technology is highly anticipated. Not only do policies continuously drive market expansion, but capital also actively invests, injecting relentless momentum into industry development.

According to data from the "2023 Medical Device and Supply Chain Annual Innovation White Paper," the surgical robot field has become one of the most highly regarded segments in medical devices. As of November 30, 2023, this sector witnessed a total of 21 financing events. Among them, the ophthalmic & microsurgical robot track recorded four financing events, emerging as an innovative technology that gained significant traction in 2023.

KouTech is the first company in 2023 to secure tens of millions of dollars in financing in this field.This year, the company moves forward. Among them,The ophthalmic surgical robot independently developed by KouTech has successfully completed product type inspection and entered the clinical trial stage., Accelerate product implementation.

Currently, in addition to the development of general-purpose microsurgical robots, ophthalmic surgical robots, otologic surgical robots, and trans-gastrointestinal endoscopic robots, KouTech has also conducted in-depth research on related instruments, software, and hardware for surgical robot use. To meet the needs of clinicians for capillary injection during surgery, KouTech...The outer diameter of the needle tube has broken through the limit of being less than 48G., almost reaching the highest in the world.

In view of the huge demand in the Chinese market, KouTech is also accelerating its market layout and has gradually started the clinical trial work for NMPA registration to comprehensively verify the safety and effectiveness of its products, thereby speeding up the market entry process of the products.

As KouTech's technology continues to advance and its clinical applications expand, this robotic system will create more value for clinical practice and drive the continuous progress and development of the medical field.

However, the company did not stop there.

In recent years, KouTech has actively expanded its overseas business. Not only has it frequently engaged in exchanges with hospitals both in and outside of China around clinical needs, achieving relevant technological breakthroughs, but it has also entered into in-depth research and development cooperation with Takeda Pharmaceutical. Together, they are exploring research in areas such as materials and processes, combining their respective field advantages to overcome existing technological challenges and develop more innovative products that better meet clinical needs.

In the future, KouTech will also expand its cooperation areas, collaborate with more industry experts, and create products that truly meet clinical needs and are oriented towards the global market.

In recent years,Microsurgical robotic systems have become an innovative field of significant attention.

From the perspective of market competition, the competition in the surgical robot sector is becoming increasingly fierce. However, in the innovative field of microsurgical robots, no industry giants have yet entered. Although the da Vinci Surgical System excels in laparoscopic procedures, it struggles to perform in more delicate operations such as those involving lymph nodes and the eye. With the rising clinical demand for minimally invasive surgeries and the continuous emergence of procedures that require high precision, a new type of surgical robot—microsurgical robots—has been developed.

From the perspective of clinical pain points, microsurgery techniques have been widely applied in fields such as corneal transplantation, vitrectomy, and retinal surgery. However, due to the high requirements for surgical resolution and precision in related surgeries, especially intraocular surgeries, limited operating space for instrument manipulation, poor visibility of the surgical environment, and physiological tremors during manual operations by surgeons, the success rate of these surgeries remains relatively low. At the same time, there is still an imbalance between supply and demand for the treatment of related diseases in China. Due to the extremely high difficulty of this surgical procedure, almost only large cities, major hospitals, or specialized hospitals in China have the capability to perform such surgeries.

Microsurgical robotic systems undoubtedly provide strong support for addressing the aforementioned challenges.

This technology can reduce hand tremors for doctors, allowing them to more easily perform high-difficulty and complex surgeries, and improve their ability to repair delicate anatomical structures. At the same time, the precision of surgical positioning is expected to enhance surgical safety, helping doctors successfully complete more complex procedures, effectively lowering the threshold for surgeries, and meeting the significant unmet needs across multiple departments such as otolaryngology, lymphatic surgery, neurosurgery, plastic surgery, and ophthalmology. In areas with relatively scarce high-quality medical resources, this technology, due to its small footprint and wide adaptability to various surgical methods, can benefit more patients.

KouTech, as the builder of the world's first robotic platform focused on small-scale precision surgeries, while successfully achieving the full-process non-tremor operation of the surgical robot system, has undoubtedly broken through the core difficulties in product development and continued to promote the implementation of related technologies.

The microsurgical robot developed by KouTech is one of the most refined surgical robots globally. The product is currently able to achieveMicron-level Single-step Motion, fully meeting the high-precision operational requirements of microsurgery.

Specifically, the diameter of the robotic end-effector wrist structureLess than 3mm, the world's smallest, able to precisely0.3mmVascular, lymphatic, and nerve anastomosis. Meet the needs of the entire surgical field, including otolaryngology, neurosurgery, vascular surgery, plastic surgery, ophthalmology, etc., to complete procedures that existing medical robots (such as orthopedic robots, endoscopic robots, vascular interventional robots, etc.) cannot perform and that require high precision.

Notably, its master-slave teleoperation soft tissue robot is equipped withMulti-degree of Freedom, which can achieve the world's smallest and most precise surgery, assist microsurgeons in completing various high-difficulty, ultra-micro精细灵巧 operations, effectively ensure surgical precision and safety, and shorten the learning curve for doctors.

In addition, the robot is equipped with delicate and long-lasting consumables, which can effectively extend the product's service life and reduce the product's usage cost. The compact design of the product allows it to be quickly deployed in various operating rooms, laying the foundation for the widespread application of the product in the future.

Currently, KouTech's microsurgical robot, with its personalized integration of medical and engineering expertise, along with a non-tremor drive system and precise, nimble forceps, has achieved a motion accuracy of up to 5 micrometers, effectively addressing unresolved pain points in current surgical procedures.

It is not easy to achieve the above technical breakthroughs. As an innovative track that has deterred giants, entering the field of microscopic surgical robots is extremely challenging. The first and foremost hurdle to overcome is the extremely high technical barrier.

Unlike orthopedic surgery, surgeries related to microsurgical robots, such as those involving the eyes, ears, blood vessels, and nerves, deal with intricate anatomical structures. These procedures must be performed with high precision and stability within narrow spaces densely packed with blood vessels and nerves. The robotic systems involved in these surgeries are not only more complex in terms of technical pathways but also involve additional precise components and processes, setting a high threshold for manufacturing and design.

To meet the requirements of surgical operations that demand a high level of precision, microsurgical robots must ensure small-scale movements, precise operations, and minimal applied forces through the implementation of relevant technologies—actions that cannot be achieved by human hands. The surgical robot system requires not only a mechanical structure design with high rigidity, a wide range of motion, high degrees of freedom, and high accuracy, but also a stable and robust base. Additionally, it must ensure that its end-effector tools are compact, finely structured, and capable of achieving precise positioning. Not only are the robot's movements highly accurate, but its force feedback system, which precisely conveys sensations to the doctor’s operating handle, provides the surgeon with a realistic sense of touch equivalent to that experienced during an actual surgical procedure.

When facing the challenge of improving product precision, the most difficult problem lies in the fact that every minor improvement in precision may require a comprehensive adjustment of the product's manufacturing process and many other aspects. This process exhibits typical "non-linear" characteristics, demanding that enterprises achieve an extremely high level in both research and development and production capabilities to ensure that every adjustment can accurately and effectively enhance the product's precision.

Fortunately,Since its inception, KouTech has collaborated with medical giants such as the Da Vinci Surgical Robot and clinical doctors.Guided by clinical needs, KouTech ensures that its products meet clinical requirements while maintaining excellent performance. In addition, the company is committed to the pursuit of refinement, miniaturization, and more precise operations. It has gathered Japan's top optoelectronic team, starting with minimally invasive microscopic technology, and established a clear implementation path including breakthroughs in core underlying technologies, supply chain establishment, product manufacturing, and process optimization.

After more than a decade of technical exploration and accumulation, the company has finally achieved self-production and self-research of the underlying components of surgical robots, as well as servo systems, transmission, and consumable components.

Building a solid technical foundation will undoubtedly provide inexhaustible momentum for the subsequent innovative iterations of the product. Relying on its four core underlying capabilities, KouTech has pioneered the Ontai-style processing system, continuously iterating existing processing technologies to improve product quality from 99% to 99.99%, making precision and micro-scale advancements possible.

The successful completion of product type inspection and the entry into clinical trials by KouTech is the best testament to the company's R&D capabilities and product safety.

Next, as companies deepen cooperation with enterprises such as Takeda Pharmaceutical and enhance exchanges with hospitals, their general-purpose microsurgical robots, ophthalmic surgical robots, otologic surgical robots, and trans-endoscopic gastrointestinal robots are all expected to achieve larger-scale commercial applications in the future. Meanwhile, KouTech will continue to adhere to innovation, constantly optimizing product performance, with the aim of achieving more technological breakthroughs and application innovations in the medical technology field.